HDAC1 and ischemic stroke: Since HDAC1, 2, and 3 are strongly expressed in the central nervous system, a promising strategy may be to develop selective inhibitors of these enzymes in order to assess their effectiveness as a new therapeutic agent for ischemic stroke.